International Flavors & Fragrances Inc. - IFF STOCK NEWS

IFF has launched a new video series, “Learning Labs,” showcasing discussions with its leadership on the company's segments and R&D functions. This initiative follows IFF's merger with DuPont's Nutrition and Biosciences, aiming to increase transparency and stakeholder communication. Additionally, IFF has provided segment-level financial details for 2020 based on pro forma results, highlighting sales and adjusted EBITDA across its four segments. Chairman and CEO Andreas Fibig emphasized the importance of connecting with investors and showcasing IFF's growth potential.

IFF has reached an agreement with Sachem Head Capital Management allowing its Managing Partner, Scott Ferguson, the option to join IFF’s Board of Directors between September 10 and December 31, 2021. This move signals IFF's commitment to enhancing shareholder engagement following discussions on maximizing synergies from its merger with DuPont's N&B business. The Board will expand from 13 to 14 directors should Ferguson join. Both IFF's leadership and Sachem Head view this agreement as beneficial for promoting long-term shareholder value.

IFF (NYSE: IFF) has declared a quarterly cash dividend of $0.77 per share, set to be paid on April 6, 2021, to shareholders recorded by March 26, 2021. This announcement reflects IFF's commitment to returning value to its investors while continuing its role as a leader in food, beverage, health, and biosciences. IFF is dedicated to creating innovative solutions that benefit both people and the planet.

IFF has appointed Dirk Lauven as Master Perfumer, recognizing his 30-year career in the global perfumery industry. Lauven, who joined IFF in 2017 and has a track record of commercial excellence, is the company’s eighth Master Perfumer. Andreas Fibig, IFF’s CEO, praised Lauven's creativity and ability to drive innovation into commercial results. Lauven expressed excitement about mentoring the next generation of perfumers. His tenure at IFF has been marked by significant growth following the acquisition of Fragrance Resources, where he previously served as CEO Europe.

IFF (NYSE: IFF) announced that CEO Andreas Fibig will speak at the Consumer Analyst Group of New York's annual conference, set for February 17, 2021, at 10:40 a.m. ET. This session will be available as a pre-recorded webcast, with a replay accessible afterward at ir.iff.com. IFF specializes in food, beverage, health, biosciences, and sensorial experiences, creating innovative solutions that enhance global consumer products.

International Flavors & Fragrances reported a mixed performance for Q4 and the full year 2020. Q4 sales totaled $1.3 billion, a slight decline from 2019. Operating profit decreased to $101 million and EPS was $0.57, down from $0.70. For FY 2020, sales stood at $5.1 billion, reflecting a 1% decline, with EPS at $3.21, compared to $4.00 in 2019. Despite challenges, leadership expressed optimism for 2021, predicting stronger results driven by an enhanced platform and reduced net debt. Pro-forma sales for 2021 are projected at approximately $11.5 billion.

DuPont announced the final results of its exchange offer related to the merger with International Flavors & Fragrances Inc. (IFF). A total of 368,655,051 shares were tendered, with a proration factor of 52.53%. Holders of 197,410,113 shares, approximately 27% of DuPont's outstanding shares, exchanged their stock for N&B common stock at an exchange ratio of 0.7180, resulting in receiving IFF shares post-merger. The transaction was supported by Goldman Sachs, J.P. Morgan, and Evercore as financial advisors.

IFF (NYSE: IFF) has unveiled a new brand identity following its merger with DuPont's Nutrition & Biosciences division, aimed at enhancing its role in the consumer goods and commercial products value chain. The new tagline, Where science and creativity meet, reflects IFF's commitment to innovation and customer-centric solutions. Key elements include a core vision of being an essential solutions partner and three commitments: Question Everything, Champion Creators, and Do More Good. The company seeks to drive sustainability and foster a strong execution culture.

IFF has successfully completed the merger with DuPont's Nutrition & Biosciences (N&B) business through a Reverse Morris Trust transaction. The new company will operate under the IFF name, with pro forma revenue exceeding $11 billion and EBITDA at approximately $2.5 billion. DuPont shareholders will own 55.4% of the combined entity, while IFF shareholders will hold 44.6%. This merger aims to create a global leader in high-value ingredients across various markets, enhancing IFF's capabilities to deliver innovative solutions tailored to increasing consumer demand for healthier products.